Monoclonal Antibody to Acetylcholinesterase (ACHE)
| Code | Size | Price |
|---|
| MAB447Hu22-20ul | 20ul | £89.00 |
Quantity:
| MAB447Hu22-100ul | 100ul | £167.00 |
Quantity:
| MAB447Hu22-200ul | 200ul | £225.00 |
Quantity:
| MAB447Hu22-1ml | 1ml | £518.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Clonality: Monoclonal
Regulatory Status: RUO
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
ARAChE; N-AChE; YT
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Ig Isotype:
IgG2a Kappa
Immunogen:
RPB447Hu01-Recombinant Acetylcholinesterase (ACHE)
Item Name:
Acetylcholinesterase
Potency (Clone Number):
C3
Reactivity:
Po;
Source:
Monoclonal antibody preparation
Subcategory:
Monoclonal antibody preparation
USAGE:
Western blotting: 0.5-3ug/mL;<br/>
Immunohistochemistry: 5-30ug/mL;<br/>
Immunocytochemistry: 5-30ug/mL;<br/>
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-30ug/mL;<br/>
Immunocytochemistry: 5-30ug/mL;<br/>
Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Acetylcholinesterase (AchE) | RPB447Hu01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||